Michael Rhodes

Title: Michael Rhodes: Innovator in Genomic Assays

Introduction

Michael Rhodes, based in San Mateo, California, is a notable inventor with a portfolio of two patents focusing on advancements in molecular biology and biotechnology. His work primarily concerns methods for ordering and delivering genomic assays, emphasizing quality and efficiency in both manufacturing and consumer delivery.

Latest Patents

Rhodes’ latest innovations include patented methods for placing, accepting, and filling orders for products and services related to assays that detect Single Nucleotide Polymorphisms (SNPs) or gene expression. These methods leverage Polymerase Chain Reaction (PCR) and Reverse Transcription PCR (RT-PCR) procedures. His patents outline processes where collections of stock assays are meticulously assembled using comprehensive pre- and post-manufacturing quality control procedures, making them easily accessible to consumers via the Internet. Furthermore, he also facilitates the preparation of custom assays upon consumer request, ensuring that they adhere to the same rigorous quality standards before being delivered directly to the consumer.

Career Highlights

Rhodes works for Applied Biosystems, LLC, a company recognized for its contributions to the field of biotechnology. His focus on improving the accessibility and reliability of genomic assays plays a critical role in advancing research and application in genetic testing and diagnostics.

Collaborations

Throughout his career, Michael has collaborated with distinguished colleagues, including Ryan T. Koehler and Kenneth J. Livak. These collaborations have enriched his research and development efforts, leading to meaningful innovations in the realm of biological assays.

Conclusion

Michael Rhodes stands out as a pioneering inventor making significant strides in the field of genomic assays. With his expertise and contributions, he enhances the landscape of molecular diagnostics, making genetic testing more efficient and reliable for consumers and researchers alike. His patents not only reflect innovation but also a commitment to quality and accessibility in biotechnology.